Ginkgo Bioworks
$6.78
566
-$0.62-8.38% 20:00 Today
+$0.12+1.77%23:08After hours
Statistics
Day High
7.31
Day Low
6.76
52W High
17.58
52W Low
5.37
Volume
1,075,376
Avg. Volume
1,189,683
Mkt Cap
456.57M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
16NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-2
-1.58
-1.17
-0.75
Expected EPS
-1.16
Actual EPS
N/A
Financials
-183.81%Profit Margin
Unprofitable170.16MRevenue
-312.76MNet Income
Analyst Ratings
7.00Average Price Target
The highest estimate is 9.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy 0%
Hold 50%
Sell 50%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow DNA. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Twist Bioscience
TWST
Mkt Cap9.13B
Synlogic
SYBX
Mkt Cap8.32M
Codexis
CDXS
Mkt Cap182.87M
Evogene
EVGN
Mkt Cap8.89M
Pacific Biosciences of California
PACB
Mkt Cap419.62M
Illumina
ILMN
Mkt Cap33.13B
CRISPR Therapeutics
CRSP
Mkt Cap5.75B
Editas Medicine
EDIT
Mkt Cap477.63M
About
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
Show more...
CEO
Jason Kelly
Employees
485
Country
United States
ISIN
US37611X2099
Listings
0 Comments
Share your thoughts
FAQ
What is Ginkgo Bioworks stock price today?▼
The current price of DNA is $6.78 USD — it has decreased by -8.38% in the past 24 hours. Watch Ginkgo Bioworks stock price performance more closely on the chart.
What is Ginkgo Bioworks stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNYS exchange Ginkgo Bioworks stocks are traded under the ticker DNA.
Is Ginkgo Bioworks stock price growing?▼
DNA stock has fallen by -2.02% compared to the previous week, the month change is a -7.88% fall, over the last year Ginkgo Bioworks has showed a -45.98% decrease.
What is Ginkgo Bioworks market cap?▼
Today Ginkgo Bioworks has the market capitalization of 456.57M
When is the next Ginkgo Bioworks earnings date?▼
Ginkgo Bioworks is going to release the next earnings report on November 16, 2026.
What were Ginkgo Bioworks earnings last quarter?▼
DNA earnings for the last quarter are -0.75 USD per share, whereas the estimation was -0.9 USD resulting in a +16.2% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Ginkgo Bioworks revenue for the last year?▼
Ginkgo Bioworks revenue for the last year amounts to 170.16M USD.
What is Ginkgo Bioworks net income for the last year?▼
DNA net income for the last year is -312.76M USD.
How many employees does Ginkgo Bioworks have?▼
As of August 24, 2026, the company has 485 employees.
In which sector is Ginkgo Bioworks located?▼
Ginkgo Bioworks operates in the Health & Wellness sector.
When did Ginkgo Bioworks complete a stock split?▼
The last stock split for Ginkgo Bioworks was on August 20, 2024 with a ratio of 1:40.
Where is Ginkgo Bioworks headquartered?▼
Ginkgo Bioworks is headquartered in BOSTON, United States.